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ACTH adrenocorticotropic hormone  
BBB blood–brain barrier 
CNS central nervous system 
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time-of-flight mass spectrometry. 
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MRI magnetic resonance imaging 
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It is becoming increasingly evident that the role of the gut microbiota (GM) is              
not limited by the walls of the gastrointestinal tract (supporting the digestion,            
absorption of nutrients, intestinal motility and resistance to pathogens), but it           
also influences normal physiology of the whole organism and contribute to the            
broad range of diseases including those affecting the central nervous system           
(CNS). 
The growing appreciation of the role of intestinal bacteria in brain physiology            
has led to the establishment of so called “gut-brain axis”, or the            
“microbiota-gut-brain axis”, a bidirectional communication network between       
the gut and the brain. 
The exact pathways of interaction are still being revealed and they include:            
immune pathway (immune signalling cells, cytokines, chemokines), endocrine        
pathway (HPA axis), neural mechanisms (vagus nerve and enteric nervous          
system) and metabolites: bacterial-derived cell wall components       
(peptidoglycans) and bacterial-derived metabolites, such as SCFAs. 
It has been reported, that gut microbiota can have an effect on brain function              
altering the levels of circulating cytokines. Recent studies consider that          
abnormal levels of cytokines/chemokines and immune cells play an important          
role in the epileptogenesis process. Furthermore, increase in cytokines has          
been reported to play a neuromodulatory role. The immune-mediated leakage          
in the blood–brain barrier (BBB) was showed to be involved in both, the             
induction of seizures and the progression to epilepsy. Moreover, the gut           
microbiota may also influence BBB permeability in mice and commensal          
intestinal microbiota was found to be able to modulate excitability of gut            
sensory neurons. 
 
Summarizing above mentioned, we hypothesized that gut microbiota form         
subjects affected by neural pathology can modulate in healthy subjects          
excitability in CNS and, finally, positively correlate with the level of seizure            
activity. 
The primary aim of the research project was to determine the impact of             
microbiota transplanted from animals with induced epilepsy to healthy         
recipient animals, in order to clarify whether the presence of the disease can             
change microbiota in the gut to the point of having a “pro-pathological”            
microbiota. 
The data obtained in this study suggests that mice received “pro-pathological”           
microbiota have compromised brain excitability. Microbiota composition of the         
donors with induced temporal lobe epilepsy (TLE) was characterised by the           
increase in ​Sutterella, Prevotella, Dorea, Coprobacillus ​and ​Candidatus        
Arthromitus ​in comparison with the baseline. These alterations, through the          
GBA, may possibly have an effect on the excitability of the brain and             







Humans through their lifetime live in cooperation with the huge amount of            
microorganisms inhabiting body cavities and all exposed and internal surfaces          
of the body.  
This community represents a complex ecosystem which is formed not only by            
microbes, but it includes bacteria, archaea, protozoa, fungi and nematodes          
(mostly parasitic).  
All collection of the microorganisms in the community is termed microbiota,           
and the collection of their genomes - microbiome. These microorganisms          
occupy distinct microbial niches where they perform tissue-specific functions         
and each of these niches may have a different composition of microorganisms.            
Among others, the most studied consortia are: oral microbiome ​(Eren, Borisy,           
Huse, & Mark Welch, 2014)​, vaginal ​(van de Wijgert et al., 2014)​, microbiome             
of the skin ​(Weyrich, Dixit, Farrer, Cooper, & Cooper, 2015)​, nasal and sinus             
microbiome ​(Wilson & Hamilos, 2014)​. 
Although microbiota composition varies a lot across body niches and time,           
corresponding bacterial communities across individuals tend to be more         
similar to each other ​(Costello et al., 2009)​. The quantitative characterization           
of the microbiota is still under the discussion. For the last four decades, one of               
the most cited and exalting paradigm was that “microbial cells outnumber           
human cells 10 times”, “we are only 10%” human” etc. ​(Luckey, 1972)​.            
Recently the amount of human and bacterial cells in the body was critically             
recalculated and the new ratio of human/bacterial cells representation was          
established = 1.3:1 ​(Sender, Fuchs, & Milo, 2016)​. 
 
At the same time, last studies confirm that the most densely inhabited organ,             
in terms of microbiota, is colon (concentration of microbial cells there arrives            
at 10​14​/cm​3​) making it the “only significant contributor within the all           
gastrointestinal tract”. For comparison a stomach has 10​3 cells​/cm​3​, duodenum          
10​3​-10​4​, ileum 10​8​ (Table 1).  
Table 1. Bounds of bacteria number in different parts of the ​gastrointestinal tract (​GIT). 
Part of digestive 
system 




Order of magnitude 
bound for bacteria 
number 
stomach  10​3​ - 10​4 250-900 10​7 
duodenum and 
jejunum 
10​3​ - 10​4 
400 10​11 
ileum 10​8 
colon 10​11 420±90 10​14 
Modified form ​(Sender et al., 2016) 
 
The total weight of the intestinal microbiome arrives to 1-2 kg, making it             
comparable with the weight of the human brain (Stilling et al., 2014); it             
represents a complex endocrine organ seems to be so crucial in the wellbeing             
of the host that it was already named as “second brain” ​(Gershon, 1999) or              
even as the “forgotten organ” ​(O’Hara & Shanahan, 2006)​. 
The experiments that will be described in this thesis are focused in this             
particular microbial niche, thus, from here, by the term of “microbiota” only            




Microbiota community in the human gut is mainly composed of strict           
anaerobes and is formed by nine divisions of bacteria: ​Bacteroidetes and the            
Firmicutes ​that are dominating and compose more than 98% of the total            
volume and ​Proteobacteria, Verrucomicrobia, Actinobacteria, Fusobacteria,      
Cyanobacteria​, ​Spirochaeates and ​VadinBE97 that are present in a smaller          
proportions. Mice showed similar patterns in the microbiota composition and          
representation of the bacterial phyla, with the exception that ​Fusobacteria and           
TM7​ were not detected ​(Ley, Peterson, & Gordon, 2006)​. 
Gut microbiota has been already recognized for the ‘in-field’ functions, closely           
connected to the physiology of the GIT, where it is responsible for the             
digestion and absorption of nutrients, fat distribution, synthesis of vitamins (K,           
B12), intestinal motility and gut barrier homeostasis ​(Bäckhed et al., 2004;           
Bercik, Collins, & Verdu, 2012)​. 
Nowadays it is becoming increasingly evident, that the role of the gut            
microbiota is not limited by the walls of the GIT, but it also contributes to               
normal physiology of the whole body playing role in metabolism, maturation           
and activity of the immune system and behavior of the host ​(Barko,            
McMichael, Swanson, & Williams, 2017)​. 
Moreover, in case of dysbiosis it was shown to contribute to the broadest             
range of diseases. Some, the most studied to date are: obesity, inflammatory            
bowel disease, metabolic syndrome, cardiovascular diseases ​(Cho & Blaser,         
2012)​, immune-Mediated Inflammatory Diseases such as rheumatoid arthritis        
and psoriasis ​(Forbes, Van Domselaar, & Bernstein, 2016) and the uprising           




Relation of Intestinal microbiota with CNS 
 
Emerging data suggest that gut microbiota has an ability to influence           
psychological state of the host. 
Many behavioral alterations were observed in germ free animals (GF) - those            
free from microbial colonization and kept under strictly sterile conditions.  
Experiments revealed deviations in the psychological state of the sterile          
animals compared to the conventional mice: they were reported to experience           
reduced anxiety-like behaviour showing more risk-taking activity, increased        
sociability, lack of normal stress responsivity and learning and memory deficits.           
Interestingly, in many cases recolonisation of the GF mice with the           
conventional microbiota leaded to normalisation of behavior manifestations        
and responses. ​(Clarke et al., 2013; Diaz Heijtz et al., 2011; Gareau et al., 2011;               
Neufeld, Kang, Bienenstock, & Foster, 2011)​. 
 
Moreover, the composition of the intestinal microbiota has been already linked           
to the pathogenesis of numerous severe neurological diseases including autism          
spectrum disorder ​(Kang et al., 2013; Wang et al., 2011)​, schizophrenia ​(Dinan,            
Borre, & Cryan, 2014) and multiple sclerosis ​(Cantarel et al., 2015; Freedman,            
Shahi, & Mangalam, 2017)​. The importance of GM alteration was also           
demonstrated in Parkinson’s disease ​(Scheperjans et al., 2015)​, Alzheimer’s         
disease ​(Mancuso & Santangelo, 2017; Zhao, Jaber, & Lukiw, 2017) and stroke            
outcome ​(Benakis et al., 2016; Winek, Engel, et al., 2016)​.  
Again, many insights on the involvement of the GM in the brain functioning             
were brought up through the studies performed on the GF animals. Mice with             
 
the lack of microbes were reported to have increased blood-brain barrier BBB            
permeability (reversed by the colonisation of these animals with the normal           
microbiota) ​(Braniste et al., 2014)​, hypermyelination of the prefrontal cortex          




Rapidly increasing appreciation of intestinal bacteria in shaping brain         
development and behaviour has led to the establishment of so called           
“gut-brain axis” ​(Foster & McVey Neufeld, 2013)​, which later was enlarged to            
the “microbiota-gut-brain axis” - especially underlining the importance of the          
gut microbiota in this alliance ​(Mayer, Tillisch, & Gupta, 2015)​. But still in the              
scientific literature gut-brain axis (GBA) is more common abbreviation, which,          
however, still involves intestinal microbiota as an important player in this field. 
The GBA is a bidirectional communication network between the gut and the            
brain. This interaction is maintaining through the mechanisms that are complex           
and they are still being revealed. To this moment, data accumulating both from             
animal research models and clinical practice suggest the presence of several           
pathways: neural, hormonal, immune pathways, and via neurotransmitters. 
Neural pathway, including the Vagus nerve (VN) and Enteric Nervous System           
(ENS). The VN (cranial nerve X) is recognized as a direct connection between             
intestine and the brain having both efferent and afferent roles. Experiments on            
the vagotomized animals showed that certain strains of bacteria can modify           
stress response, anxiety, depression and cognition of the host and these           
effects are dependent on the vagus nerve, identifying it as a major pathway             
between the bacteria inhabiting the gut and the brain ​(Bravo et al., 2011)​. 
 
In addition to this direct communication, vagal-independent interaction also         
takes place. Microbiota constantly directly interacts with ENS – the largest part            
of the autonomic nervous system which contains approximately 50,000         
extrinsic sensory neurons and 100 million intrinsic afferent neurons         
(Blackshaw, Brookes, Grundy, & Schemann, 2007; Furness, 2006) responsive to          
bacteria. They include motor neurons, interneurons and intrinsic primary         
afferent neurons (IPANs) which detect mechanical and chemical stimuli directly          
from the lumen. ​(Nagy & Goldstein, 2017)​. However, mechanisms by which           
ENS can modulate GBA are currently unclear. 
 
Hormonal pathway ​is working through the hypothalamic-pituitary-adrenal       
(HPA) axis - crucial system for providing a physiological adaptation of the            
organism to the stress ​(Herman et al., 2016)​. The HPA axis regulates the             
secretion of cortisol. This stress-related hormone can change gut barrier          
homeostasis and microbiota composition ant alter gut permeability        
(O’Mahony, Hyland, Dinan, & Cryan, 2011)​. Alterations of the microbiota          
composition have been already widely associated with the stress, especially if           
occuring in the early life. ​(De Palma et al., 2015; Golubeva et al., 2015; Sudo et                
al., 2004)​. Maternal separation in rats was reported to alter the microbiota            
composition in pups ​(O’Mahony et al., 2009)​. ​Experiments comparing a GF           
mice with a conventional mice revealed basal differences in biomarkers related           
to the stress response and showed that after the restraint test animals who             
had no exposure to the microorganisms had higher level of the           
adrenocorticotropin hormone (ACTH) in plasma and corticosterone elevation.        
What is more, this response in GF mice was reversed by recolonization with             
Bifidobacterium infantis​ ​(Sudo et al., 2004)​. 
 
Apart from the changes in the composition of the microbiota under the            
condition of stress, the HPA axis can be also influenced by the bacterial-derived             
metabolites, such as short chain fatty acids (SCFAs), produced by fermentation           
of the dietary fibers by intestinal bacteria. SCFAs, by binding to the intestinal             
G-coupled receptors, were shown to induce the secretion of the hormones           
from enteroendocrine cells ​(Samuel et al., 2008)​.  
Taken together, exact mechanisms by which endocrinology-based mechanisms        
are taking part in microbiota - brain interaction have not been elucidated yet,             
but the evidence from the stress-related research suggest this pathway as a            
potential target for the regulation of the GBA. 
 
Immune pathway (immunal signalling molecules, cytokines, chemokines) 
It was shown that intestinal microbiota is required for the normal development            
and maturation of the innate and adaptive immune systems ​(Chow, Lee, Shen,            
Khosravi, & Mazmanian, 2010)​. Later on, both these systems are involved in            
maintaining homeostasis on the luminal surface of the intestine (the primary           
interface between the microbiota community and internal host tissues), what          
is crucial for maintaining health of the host ​(Duerkop, Vaishnava, & Hooper,            
2009)​. 
Also in this case, studies in a GF mice reveal significant deviations in             
comparison to the animals housed under specific pathogen free conditions. A           
GF animals appear to have fewer and smaller mesenteric lymph nodes and            
Peyer's patches, and deviations in the composition of the diffuse          
gut-associated lymphoid tissue (GALT) - primary components for immune         
response against pathogens. Notably, the number of the intraepithelial         
lymphocytes was increased after the colonization of GF rodents with an intact            
 
microbiota ​(Falk, Hooper, Midtvedt, & Gordon, 1998; Kwa, Beverley, & Smith,           
2006; Round & Mazmanian, 2009)​.  
Intestinal immune homeostasis is maintained through the balanced        
communication between pro- and anti-inflammatory mechanisms affected by        
the microbial activity in the gut. 
Emerging data suggest that intestinal microbiota can influence the alteration of           
circulating levels of inflammatory and anti-inflammatory cytokines,       
chemokines and immune signaling molecules ​(Alam, Abdolmaleky, & Zhou,         
2017) and modulate low-grade inflammation both in the gut and systemically           
(Cryan & Dinan, 2012; Pisanu & Squassina, 2017)​. 
 
Influence the level of  neurotransmitters  
Some bacteria were shown to have a capacity to synthesize and release several             
neurotransmitters and neuromodulators: for example, Candida spp.​,       
Streptococcus spp​. and ​Escherichia spp​. act in serotonin production, ​Bacillus          
spp​. can produce dopamine, some species of ​Lactobacillus - acetylcholine,          
Escherichia spp​., ​Bacillus spp. and ​Saccharomyces spp​. produce noradrenaline.         
One of the most important inhibitory neurotransmitters - gamma-aminobutyric         
acid - can be produced by certain species of ​Lactobacillus​ and ​Bifidobacterium​.  
It was proposed that neuroactive metabolites produced by the microbiota are           
important not only for the interaction with the host, but also as a way of               
communication between members of the microbiota community ​(Lyte, 2010)​.  
 
Conclusion: 
Constant functioning interaction between the microbiota, gut and the brain,          
either directly via vagus nerve and microbial metabolites or indirectly through           
endocrine and immune pathway appears to be crucial for the normal           
 
physiology of the host. Further studies are needed to elucidate the numerous            
unrevealed factors in this complex communication network. 
Temporal Lobe Epilepsy  
 
Epilepsy is a life-threatening progressive neurological disorder characterized by         
uncontrolled abnormal brain activity clinically manifesting as recurrent        
unprovoked seizures. 
It affects 50-65 million people worldwide. Estimated 0.5-1% of the population           
in developed countries suffer from this disease, and almost 2 times more in the              
developing. And each year 2.4 million people are becoming diagnosed with           
epilepsy. These numbers become even more dramatic when we face the fact            
that about a third part of all the cases are still considered to be incurable and                
patients can undergo only neurosurgery, symptomatic treatment or other         
beneficial therapy such as neurostimulation or special diet, which, however,          
may not guarantee a seizure-free life ​(Moshé, Perucca, Ryvlin, & Tomson,           
2015; “WHO | Epilepsy,” 2017)​.  
 
Approximately 60% of all people living with epilepsy are diagnosed with the            
temporal lobe epilepsy (TLE) - the most frequent type of focal (partial) epilepsy             
and, regrettably, the most common cause of drug-resistant seizures. Even          
though the antiepileptic drugs are affordable and inexpensive to control or to            
reduce seizure occurrence, but approximately one third of patients remains          
resistant to pharmacological treatment ​(Löscher & Potschka, 2005; “WHO |          
Epilepsy,” 2017)​. Epilepsy has no geographical, racial or social boundaries and           




There are two types of the TLE. The first, most common one, is medial TLE, it                
involves the medial or internal structures of the temporal lobe; while the            
second, called neocortical TLE, involves the outer portion of the temporal lobe.  
In clinical practice symptoms of TLE are manifesting as seizures that originate            
from the hippocampus, entorhinal cortex or amygdala that can be developed           
many years after SE. Diagnosis is based mainly on the results from the             




Involvement of Neurovascular unit in pathophysiology of Epilepsy 
 
An epileptic seizure, as defined by the ILAE “a transient occurrence of signs             
and/or symptoms due to abnormal excessive or synchronous neuronal activity          
in the brain” results from the abnormal synchronization of the neurons that            
disturbs the physiological excitation and inhibition balance and disrupts         
neuronal communication ​(Fisher et al., 2017)​. 
For many years epilepsy was considered as a “neuron-firing” disease, making           
affected neurons the most important contributors to the pathogenesis. Recent          
studies revealed that in fact the neuronal activity depends on the strong            
interaction between neurons, glial cells, BBB permeability, vascular        
endothelium, humoral network (including cytokines and chemokines) and also         
non-neuronal immune-related blood cells; what is rising a new paradigm          
considering this integrated system of the neurovascular unit (NVU) as an           
extremely important complex for the understanding pathogenesis of epilepsy         
(Bertini et al., 2013)​.  
The NVU represents a concrete anatomical and functional structure including:          
neurons, the BBB, glial cells, pericytes, leukocytes, the humoral network:          
cytokines, chemokines and extracellular matrix. 
Each of these components contribute to the pathogenesis of epilepsy in direct            
and indirect ways: BBB damage was reported to be “a hallmark of seizure             
activity”, and it is involved both in the induction of seizures and progression to              
chronic state of disease ​(Marchi et al., 2010; Marchi & Lerner-Natoli, 2013)​.            
Pericytes were shown to modulate BBB integrity (their deficiency is leading to            
leaky BBB) and now they seem to have an important role in the activity of the                
epileptic brain ​(Milesi et al., 2014)​. 
 
Accumulating data both, from research models and clinical practice, suggest          
that also leukocytes, especially leukocyte-endothelial adhesion mechanisms,       
have an important role in the pathogenesis of epilepsy. It was shown that             
leukocyte trafficking mechanisms provoke BBB leakage which as it was already           
mentioned is leading to the seizure activity. Recent studies revealed that           
blockage of leukocyte-vascular adhesion prevented BBB disruption in animal         
model of epilepsy ​(Fabene et al., 2008)​. This is supported with the insights             
from the clinical practice: patients with different types of epilepsy reported to            
have more leukocytes in brain parenchyma in comparison with controls          
(Fabene, Laudanna, & Constantin, 2013)​. 
Closer look to the humoral network, another component of the NVU, can help             
for better understanding of the seizure origins. Here, chemokines - small           
secreted proteins that primarily control the migration and activation of the           
immune cells play role. Recently, chemokines, besides their immunological         
competence, were shown to have neuromodulator and neurotransmitter-like        
effects ​(Stuart & Baune, 2014) and to be able to modulate the above             
mentioned mechanism of the leucocyte-vascular adhesion. Another players of         
the humoral network are cytokines, small soluble mediators that are crucial in            
immune regulation. They appear to modulate the thalamo-cortical        
synchronisation: for example, it was shown that pro-inflammatory cytokine         
IL-1β have a pro-convulsant effect ​(Vezzani et al., 2002)​.  
Thus, the NVU represents a complex system deeply involved in the brain            





Role of inflammation in pathogenesis of epilepsy 
The concept of neurovascular unit as a complex integrated system is important            
for introducing one of the recently emerged factors of epileptogenesis -           
inflammation. Growing body of literature suggests that inflammatory        
mechanisms have an important ​role in the development, progression and          
occurence of the seizure activity. What is more, seizures ​per se ​can induce             
inflammation of the brain and recurrency is leading to the chronic           
inflammation ​(Vezzani, French, Bartfai, & Baram, 2011)​.  
 
From the clinical practice it was reported that prolonged or focal febrile            
seizures (those induced by fever) in childhood have been associated with the            
occurrence of intractable form of the TLE epilepsy ​(Dubé, Brewster, Richichi,           
Zha, & Baram, 2007)​. Also, human brain tissue obtained during the surgical            
resection of the seizure focus in patients with refractory focal epilepsy           
appeared ho have significantly more biomarkers of inflammation than healthy          
individuals ​(Vezzani et al., 2011)​.  
In vitro and ​in vivo research models offer a huge advantage for the better              
investigation of the inflammatory process that can trigger (or be triggered by)            
seizure activity. Available studies highlight several mechanisms that contribute         
to the epilepsy-related inflammation. These are: neuroinflammation, vascular        
inflammation, BBB leakage, recruitment of inflammatory cells,       
leukocyte-endothelial adhesion, etc. Inflammatory mediators were also shown        
to be involved ​(Bertini et al., 2013)​. 
Thus, evidence from the clinical practice and numerous animal models suggest           
that inflammation might be both a consequence and a cause of epilepsy.   
 
Hypothesis Gut microbiota-Inflammation-Epilepsy 
B​ased on the previously reviewed data: 
● Abnormal levels of cytokines/chemokines and immune cells were        
reported to have an important role in epileptogenesis ​(Fabene,         
Bramanti, & Constantin, 2010; Li et al., 2011)​. 
The immune-mediated leakage in the BBB is involved in both, the induction of             
seizures and the progression to epilepsy ​(Fabene et al., 2008)​. 
And on the other “side”: 
● Gut microbiota can have an effect on brain function altering the levels of             
circulating cytokines ​(Cryan & Dinan, 2012)​. 
● The GI represents a vulnerable surface through which pro pathogenic          
microorganisms can influence various aspects of physiology and cause         
inflammation in the central nervous system ​(Catanzaro et al., 2015)​. 
● New evidenced are emerging on the fact that the commutal intestinal           
microbiota is able to modulate the excitability of intestinal sensory          
neurons ​(Neufeld et al., 2011)​. 
Summarizing the above mentioned data, we hypothesized that gut microbiota          
from subjects affected by neural pathology can modulate in healthy subjects           
excitability in CNS and finally positively correlate with the level of seizure            
activity (Fig. 1). 
 
Figure 1. Hypothetical relation of GM with brain excitability via inflammatory pathways. 
 
Experiments 
Part I. Establishment of the experimental groups of the         
microbiota donors 
Rationale 
Changes in the microbiota composition were shown to be associated with           
several neurological pathologies. The present project aims to (i) examine an           
impact of pathological conditions of the nervous system (chronic epilepsy) on           
the composition of gut microbiota and (ii) the ability of the pro-pathological            
microbiota to influence the excitability of the brain through lowering the           
threshold of the seizure activity. 
The primary aim of present study is to establish and describe experimental            
groups of microbiota donors and create a biobank with the fecal microbiota            
samples for the next step inoculations.  
 
Experimental design 
Pilocarpine mouse model of the TLE 
Among all the types of epilepsy, temporal lobe epilepsy has one of the highest              
representation of the therapy-resistant cases. The patho(physio)genesis of TLE         
is still being revealed and the use of animal models are essential to discover              
the exact pathways. 
In clinical practice TLE is usually characterized with the localization of seizures            
in the limbic system, particularly in the hippocampus, entorhinal cortex and           
amygdala ​(Bartolomei et al., 2005)​; “initial precipitating injury” which appears          
before the diagnosis of TLE ​(Mathern, Adelson, Cahan, & Leite, 2002)​; a            
 
seizure-free period known as “latent” or “silent” period; and frequently          
observed presence of the hippocampal sclerosis. 
Most of the above mentioned features can be reproduced in mouse model by             
the systemic injection of the muscarinic cholinergic agonist - pilocarpine          
hydrochloride ​(Curia, Longo, Biagini, Jones, & Avoli, 2008)​.  
Administration of the drug is leading to ​status epilepticus (SE) development,           
after a latent seizure free period, to spontaneous recurrent seizures (SRSs)           
occurrence and resulting in a chronic condition of epilepsy ​(Navarro Mora et            
al., 2009)​. ​Thus, the pilocarpine model of epilepsy in mice is by now one of the                
most studied, well-characterized and widely used in laboratory practice since it           
was first described in 1983 ​(Turski et al., 1983)​. 
The dosage and the way of the drug-administration can be modified depending            
on the aims of the experiment. 
For this work we based on the optimal conditions proposed by Mazzuferi et al. 
(Fig. 2a) that are producing the highest response (50%) associated with the 
best survival rate of the animals (90%) ​(Mazzuferi, Kumar, Rospo, & Kaminski, 
2012)​.  
Figure 2a. Timeline of TLE mouse model used in the experiments. 
 
General description 
To induce epilepsy and establish experimental groups NMRI mice were injected           
with the corresponding drugs (Fig. 2b). Only male mice were used, as both             
from clinical practice in women and laboratory practice in female rodents,           
gonadal hormones (estrogen, progesterone) were reported to deeply affect         
neuronal excitability and the physiological response for the        
pilocarpine-induced SE ​(Scharfman et al., 2005; Scharfman & MacLusky, 2006)​. 
  
 
Figure 2b. Flowchart of the experiment aiming to establish groups of “pro-pathological”            
microbiota donors. 
 
The first group of animals were injected according to the pilocarpine model for             
the TLE. 
Before the pilocarpine mice were injected with the methylscopolamine to          
minimize peripheral cholinergic effects ​(Curia et al., 2008)​. 
The second group was pre-treated with the bolus dose of the Diazepam –             
positive allosteric modulator of the GABA​A chloride channel ​which was          
 
reported to have ​anticonvulsant properties and which is broadly used to           
terminate the convulsive SE ​(Calcaterra & Barrow, 2014)​. 
Pre-treatment with Diazepam in our case has the role of inhibiting the            
development of pilocarpine-induced seizures, providing also the       
neuroprotective effect ​(Radzik, Miziak, Dudka, Chrościńska-Krawczyk, &       
Czuczwar, 2015)​. 
The third group was the naïve controls. Detailed protocol of injections is            
reported in the ‘Materials & Methods’ section. 
Next, the 40 days after drugs injections fecal samples were collected to create             
a biobank for the next experiments considering fecal microbiota         
transplantation (FMT). Circadian rhythm has been shown to have an impact on            
the composition of the murine microbiome ​(Liang & FitzGerald, 2017)​. Thus, all            







Materials and Methods 
Animals 
 
NMRI male mice (Charles River, France) 7 weeks old (weighing 32-38g) were            
used. After injections animals were kept 1 per cage under controlled           
environmental parameters (inverted 12:12 light-dark cycle, temperature 22 ±         
1°C, humidity 50–60%, food and water ​ad libitum​) in Optimice® cages (Animal            
Care Systems Inc., Centennial, USA). 
Animal care and experimental procedures were conducted in accordance with          
the guidelines of the European Union directive 2010/63/EU and all protocols           
were approved by local ethical committee (Centro Interdipartimentale di         
Servizi per la Ricerca che utilizza Animali da Laboratorio – C.I.R.S.A.L.,           





The pilocarpine murine model for the study of temporal lobe epilepsy is widely             
used and accumulated knowledge within the scientific community allows to          
design the experiment minimizing the number of animals and maximizing the           
obtained results.  
Furthermore, studies must be done ​in vivo to have an ability to observe             
changes in brain function and behavior manifestations. 
  
 
Induction of ​Status epilepticus​ and epileptogenesis 
Status epilepticus ​(SE) was elicited by the intraperitoneal injection of          
pilocarpine (Sigma, 300 mg/kg, i.p). In order to reduce the peripheral           
cholinergic effects of pilocarpine (PILO) animals were injected with a          
scopolamine methyl nitrate (Sigma) in a dose 1 mg/ kg, i.p 30 minutes before              
PILO. Additional group of animals received a bolus dose of Diazepam (10            
mg/kg, i.p) twenty minutes prior to methyl scopolamine. Control group was           
formed by mice injected with the corresponding volumes of saline (Fig. 3). 
 
 
Figure 3. Protocol of the injections for establishing experimental groups. 
 
Behavioral observation was performed for the period of 2 hours; severity of            
the behavioral manifestations were defined according to the modified Racine’s          
scale (Hellier & Dudek, 2005). Stages 5 and 6 were defined as convulsive SE              
(Table 2). At the end of observation animals were kept 1 per cage in the               
controlled environment. 
To evaluate the presence of SRSs animals were visually observed for 8 hours             
per day during the dark phase from the 7​th day after the induction until at least                





Table 2. The scale of seizures severity based on behavioral manifestations.  
Stages Behavioral sings 
Stage 0 no abnormality 
Stage 1 mouth and facial movement, shivering 
Stage 2 head nodding, stiff tail 
Stage 3 forelimb clonus, chewing 
Stage 4 rearing with forelimb clonus, tonic immobility 
Stage 5 rearing and falling with forelimb clonus (tonic clonic-seizure) 
Stage 6 running seizures and involuntary jumping in the cage 
Modified from ​(Karlócai et al., 2011)​.  
 
Afterwards, animals were divided in 4 groups: 
· Pilo-SE = received methyl scopolamine (MSC) and Pilocarpine, entered          
to the SE and after a seizure-free period developed spontaneous          
recurrent seizures (SRSs) 
· Pilo-noSE = received MSC and Pilocarpine, did not exhibit SE and after a              
seizure-free period did not develop SRSs. 
· Diazepam treated = received Diazepam before MSC and Pilocarpine did           
not exhibit SE and after a seizure-free period did not develop SRSs. 




Fecal sample collection 
Fecal samples were obtained 2 days before and 40 days after the induction of              
the SE. Samples for the future inoculations were collected in a sterile 1.5 ml              
plastic vials prefilled with the sterile 30% Glycerol solution, frozen and stored            
in -80°C until use for the subsequent inoculation of recipients.  
Donor material used for the analysis was collected in the in sterile 1.5 ml tubes               
without Glycerol solution, and immediately frozen in -80°C. 
Due to the fact that animals of Pilo-SE group were hypersensitive and difficult             
to handle, fecal samples from all groups were collected not directly in the             
tubes, but by letting mice defecate normally in the sterile empty cages. Next,             











Characterization of bacterial composition in fecal biobank by cultivation of bacterial           
colonies 
 
To determine a presence of bacterial forms in fecal samples, cultivation of            
bacteria colonies and followed matrix-assisted laser desorption/ionization       
time-of-flight mass spectrometry (MALDI-TOF MS) analysis was performed (Fig.         
4). This type of analysis was reported to be rapid and sensitive alternative to              
genomic-based approaches for identification of the microorganisms ​(van Veen,         
Claas, & Kuijper, 2010)​. 
 
 
Figure 4. Schematic flow-chart of the MALDI-TOF MS analysis 
 
Cultivation  
Frozen fecal samples were first weighed, dissolved in 2 ml of a sterile             
physiological solution and than mixed for 30 minutes at the room temperature.            
Afterwards, the aliquote (0.5 ml) of suspension was used for a cultivation in a              
Petrie’s dish with a blood agar substance. Moreover, using the “umbrella”           
method (i.e. dissolving of primary suspension by adding a sterile physiological           
 
solution) were prepared 10, 100 and 1000 times “diluted” samples. This step            
was necessary to examine presence of specific bacteria population in samples           
by elimination of interfering between fast and slow growing bacterial cultures.           
Aliquots (0.5 ml) of every diluted primary suspension were as well cultivated.            
In total, 5 technical repetitions of every prepared suspension were used for            
cultivation on a blood agar under aerobic condition for 18 hours at 37° C.              
Grown colonies of bacteria were analysed by MALDI-TOF mass spectrometry as           
described elsewhere ​(Kolínská, Spanělová, Dřevínek, Hrabák, & Zemličková,        
2015)​. 
MALDI-TOF MS 
Small amount of individual bacterial colonies was deposited in ten replicates of            
each sample onto a polished steel MALDI plate in the form of a thin film               
covered with 1 µl of matrix solution, comprised of a saturated solution of             
α-cyano-4-hydroxycinnamic acid (Bruker) in 50% acetonitrile (Sigma-Aldrich)       
and 2.5% trifluoroacetic acid (VWR) and allowed to dry. Mass spectra were            
acquired using a MALDI-TOF mass spectrometer (Microflex LT; Bruker         
Daltonics, Bremen, Germany). 
Microflex was equipped with a nitrogen UV laser (λ=337 nm) at a frequency             
of 20 Hz with pulsed ion extraction and automated spectra acquisition. Prior to             
the measurement, the instrument was calibrated with Bruker Bacterial Test          
Standard Escherichia coli (# 25534) using multipoint quadratic calibration         
curve. A total of 40 laser shots were accumulated from each sample. The ions              
were accelerated into the mass analyzer using 20.00-kV acceleration and          
18.65-kV extraction voltages. The mass range of spectra analyzed was from 2            
000 to 20 000 m/z. Mass spectra were processed using the software Flex             
Analysis (version 3.4; Bruker Daltonics).  
 
 
Following taxonomy database were used to determine individual bacteria         
species:  
1. Bruker Taxonomy 2017 – 7311. 
2. Security Relevant Library for Highly Pathogenic Microorganisms. 
3. Database of new ​Acinetobacters ​(Radolfova-Krizova, Maixnerova, & Nemec,         
2016)​. 
4. New taxons of ​Staphylococcus, ​NRL/St ​(Švec et al., 2015)​. 
Below mentioned individual bacteria species were determined: 
● Acinetobacter johnosnii ​is a Gram-negative, strictly aerobic bacteria        
usually inhabiting environment and occasionally colonizing human skin        
(Montaña et al., 2016)​. ​It can r​arely cause human infections, especially           
those of CNS. Several case reports were published regarding         
Acinetobacter johnosnii ​as a causative pathogen of the meningitis         
(Chang, Lu, Huang, & Chuang, 2000)​. 
● Bacillus cereus is a ​widely-distributed, gram-positive or variable. B.         
cereus rarely causes bacteremia, mainly in immunocompromised       
individuals ​(Brouland, Sala, Tusgul, Rebecchini, & Kovari, 2018)​. 
● Enterococcus faecalis - Gram-positive, commensal bacterium inhabiting       
the gastrointestinal tracts of humans and other mammals. It can be a            
cause life-threatening infections in humans, and it was shown to have           
high levels of antibiotic resistance. 
● Escherichia coli ​- Gram-negative, facultative anaerobic bacterium. E. coli         
can secret pro-inflammatory neurotoxins that were recently were shown         
to influence the function of neurons in the CNS. It was reported that in              
brain lysates from the patients with Alzheimer’s disease the presence of           
bacterial lipopolysaccharide (LPS) was determined recognising      
 
microbiota-derived LPS contribution to the inflammatory processes in        
the CNS ​(Zhao et al., 2017)​. 
● Lactobacillus murinus is a Gram-positi​ve​, facultative anaerobic or        
microaerophilic bacteria that makes major part of the lactic acid bacteria           
group - one of the most numerous presented in different body sites (GIT,             
urinary tract, genital system). In animal model abundant presence of the           
Lactobacillus spp. were reported to correlate with the low level of           
inflammation ​(A. K. Hansen, Friis Hansen, Krych, & Nielsen, 2014) and to            
be able to modulate intestinal dendritic cell functions ​(Huang, Shen,          
Liang, & Jan, 2016)​. 
● Lysinibacillus sphaericus (reclassified - previously known as ​Bacillus        
sphaericus​) ​(Ahmed, Yokota, Yamazoe, & Fujiwara, 2007) is a         
Gram-positive bacterium commonly distributed in soil. 
● Staphylococcus spp. is a genus of Gram-positive bacteria that,         
compounding Firmicutes phylum, is frequently distributed in the nose,         
respiratory tract, and on the skin. CNS infections caused by          
Staphylococcus spp., are uncommon and ​may occur as a complication of           
surgical procedures (eg. postoperative meningitis) or hematogenous       






Characterisation of the microbiota composition in fecal biobank by 16S ribosomal           
RNA (rRNA) gene sequencing  
 
DNA isolation 
Fecal pellets from mice were collected in sterile microtubes and stored at            
–80°C until bacterial DNA was extracted. DNA of the fecal samples was isolated             
with DNeasy PowerSoil DNA Isolation Kit (MO BIO Laboratories, Inc., Carlsbad,           
CA, USA) according to the manufacturer’s instructions with the slight          
modification: the temperature during primal vortexing was increased till 65°C.          
The quality and quantity of DNA were assessed (NanoDrop 1000, Thermo           
Scienti c, Waltham, MA). 
 
High-throughput sequencing  
Tag-encoded 16S rRNA high-throughput sequencing (NextSeq, Illumina) was        
used to determine the composition of the fecal microbiota. The V3 region            
(~ 190 bp) of the 16S rRNA gene was amplified using primers compatible with              
Nextera Index Kit (Illumina): NXt_388_F: 5′-TCGTCGGCAG CGTCAGATGT       
GTATAAGAGA CAGACWCCTA CGGGWGGCAG CAG-3′ and NXt_518_R:      
5′-GTCTCGTGGGC TCGGAGATGTG TATAAGAGAC AGATTACCGC    
GGCTGCTGG-3′ (Integrated DNA Technologies). PCR reactions were       
performed on on a SureCycler 8800 using mixture of 12 μL AccuPrime™            
SuperMix II (Life Technologies), 0.5 μL of each primer (10 μM), 5 μL of genomic               
DNA (~ 20 ng/μL) and 7 μ of nuclease-free water (total volume of 25 μL). PCR                
conditions were applied as described below: 95 °C for 2 min; 33 cycles of 95 °C                
for 15 s, 55 °C for 15 s and 68 °C for 30 s; followed by final step at 68 °C for 5                       
min. To incorporate primers with adapters and indexes, PCR reactions          
contained 12 μL Phusion High-Fidelity PCR Master Mix (Thermo Fisher          
 
Scientific), 2 μL corresponding P5 and P7 primer (Nextera Index Kit), 2 μL PCR              
product and nuclease-free water for a total volume of 25 μL. Cycling            
conditions: 98 °C for 1 min; 12 cycles of 98 °C for 10 s, 55 °C for 20 s and 72 °C                      
for 20 s; and 72 °C for 5 min. Purification of amplified fragments with adapters               
and tags were performed by using AMPure XP beads (Beckman Coulter           
Genomic). Prior to library pooling clean constructs were quantified using a           
Qubit Fluorometer (Invitrogen) and mixed in approximately equal        
concentrations to ensure even representation of reads per sample followed by           
NextSeq (Illumina) sequencing performed according to the instructions of the          
manufacturer. 
First step after receiving the raw data set containing pair-ended reads with            
corresponding quality scores was to merge and trim it using fastq_mergepairs           
and fastq_filter scripts implemented in the UPARSE pipeline (Edgar, 2013). The           
minimum overlap length of trimmed reads (150 bp) was set to 100 bp. The              
minimum length of merged reads was 150 bp. The max expected error E = 2.0,               
and first truncating position with quality score N ≤ 4. Purging the dataset from              
chimeric reads and constructing de novo Operational Taxonomic Units (OTU)          
were conducted using the UPARSE pipeline (Edgar, 2013). The green genes           
(13.8) 16S rRNA gene collection was used as a reference database (McDonald            
et al., 2012). Quantitative Insight Into Microbial Ecology (QIIME) open source           
software package (1.8.0 and 1.9.0) was used for subsequent analysis steps           
(Caporaso et al., 2010). 
The α diversity measures expressed for an observed species (sequence          
similarity, 97% OTU) value were computed for rarefied OTU tables (48000           
reads per sample) using the α rarefaction workflow (QIMME v1.8.0).          
Differences in α diversity were determined by using a t test-based approach            
according to the nonparametric (Monte Carlo) method (999 permutations)         
 
implemented in the Compare α Diversity workflow (QIMME v1.8.0) 
Principal coordinate analysis (PCoA) was conducted with the jackknifed beta          
diversity workflow based on 10 distance metrics calculated using 10          
subsampled OTU tables. The number of sequences taken for each jackknifed           
subset was set to ~ 85% of the sequence number within the most indigent              
sample (48000 reads/sample). Adonis, a nonparametric statistical method was         
used to evaluate group differences using weighted and unweighted UniFrac          
(Lozupone & Knight, 2005) distance matrices that were generated based on           
rarefied (48000 reads/sample) OTU tables. The relative distribution of the          
genera registered was calculated for unified and summarized in the genus level            
OTU tables.  
The database output for genus ​Candidatus Arthromitus ​was reflected in the           
‘Results’ and ‘Discussion’ sections.  
Recently it was reported that the bacterium ​Candidatus Arthromitus ​truly          
inhabits arthropod guts and belongs to ​Lachnospiraceae ​(Thompson, Vier,         
Mikaelyan, Wienemann, & Brune, 2012)​. ​To avoid the mismatch of two           
appeared to be distinct lineages the provisional name '​Candidatus Savagella​'          
was proposed. Last one belongs to the family of ​Clostridiaceae and refers to             













Induction of the epilepsy  
From a total of 40 animals injected with MSC+Pilo:  
➢ 14 entered to the SE (Pilo-SE group); 
➢ 11 entered to the SE and consequently died; 
➢ 15 did not enter to the SE (Pilo-noSE group). 
From 18 mice pre-treated with Diazepam (Diaz group) and from 12 Control no             
one entered to the SE. 
 
SRSs (behavioral manifestations) were detected in all animals from Pilo-SE          
group. Mice pre-treated with Diazepam and Pilo-noSE group did not enter to            
the convulsive SE after Pilo injection and did not develop SRSs (based on             
behavioral observations). 
 
Evaluation of the alterations in the brain in established experimental groups           
revealed that on the structural level Pilo-SE group (the only group of animals             
who experienced convulsive SE) differs from all the other groups (Pilo-noSE,           
Diazepam and Control) that appear to have similar conditions.  
What is more, after the implantation of the electrodes and measuring           
electrophysiological activity, obtained data suggested that of the functional         
level, Pilo-SE, Pilo-noSE and Diazepam groups show similar alterations. Detailed          
evaluation will be presented in the second part of the thesis. 
  
 
MALDI-TOF MS determination of bacteria populations in experimental samples  
Cultivation of bacteria colonies and followed MALDI-TOF mass spectrometry         
analysis revealed that ​Bacillus cereus, ​Escherichia coli​, ​Lactobacillus murinus         
and ​Enterococcus faecalis were equally observed in all samples in all 4 groups             
(Fig. 5).  
Significantly less appearance of ​Staphylococcus sciuri ana ​Staphylococcus        
aureus were found in all groups injected with pilocarpine (Pilo-SE, Pilo-noSE,           
Diazepam) in comparison with Control. In addition, ​Acinetobacter johnosnii​,         
Staphylococcus cohnii and ​Staphylococcus xylosus appeared only in these         
groups injected with the pilocarpine (Pilo-SE, Pilo-noSe, Diazepam). 
 
 
Figure 5. Appearance of isolated bacteria determined by the MALDI-TOF MS.  
Control (n=3); Pilo-SE (n = 4); Pilo-noSE (n = 9); Diazepam (n = 9). 
Two-sided chi-square test was used to evaluate the difference between the groups as             
described elsewhere ​(Ludbrook, 2008)​. P values <0.05 were taken as significant.  
Yellow background indicates the presence of the corresponding bacteria in the analysed            
samples, blue background - absence. Black dot (●) indicates significant difference vs            




Phylogenetic analysis of the microbiota composition in fecal biobank 
 
Fecal samples from animals were analysed at two time-points: 
● after habituation and before the injections (Baseline); 
● 40 days after the SRSs detection (Pilo-SE group) or 40 days after the             
injections (Pilo-noSE, Diazepam and Control groups) in case of no SE and            
SRSs. 
 
In the group of animals injected with pilocarpine, who entered to SE and             
developed SRSs (animals with chronic epilepsy, Pilo-SE group) there is no           
significant difference in number of genera (OTUs), but there is a significant            
difference (P = 0.028) in richness of microbiota in samples after injection (Fig.             
6). 
 
    A       B
 
Figure 6. A. Number of observed species - operational taxonomic units (OTUs) in Pilo-SE              
group. B. Phylogenetic diversity between the observed bacteria in Pilo-SE group. 
1.Baseline (n=6) represents group of the animals before the injection with the pilocarpine.  




The following changes in operational taxonomic units (OTUs) in Pilo-SE group           
were observed (Table 3). 
  











P value  
f__Alcaligenaceae; 
g__Sutterella 
↑ 0.0007 0.0976 0.0033 
f__Planococcaceae; ↑ 0.0000 0.0233 0.0073 
f__Staphylococcaceae;
g__Staphylococcus 
↑ 0.0000 0.0299 0.0073 
f__Clostridiaceae; 
g__Clostridium 
↓ 0.0719 0.0069 0.0123 
f__Prevotellaceae; 
g__Prevotella 
↑ 0.2830 1.2733 0.0163 
f__Lachnospiraceae; 
g__Dorea 




↑ 0.0403 0.2118 0.0370 
f__Erysipelotrichaceae;
g__Coprobacillus 
↑ 0.0111 0.1281 0.0463 
Observed changes in OTUs in Pilo-SE group (40 days after the confirmed SRSs)             
corresponding to the baseline (before the injection of the pilocarpine). 
 
There was no significant difference in number of genera and richness of            
microbiota in samples of Pilo-noSE, Diazepam and control. But the following           





















↑ 0.0438 0.3035 0.0019 
f__Lachnospiraceae 
g__Butyrivibrio 
↑ 0.0052 0.1024 0.0155 
f__Bacteroidaceae 
g__Bacteroides 
↓ 0.0423 0.0210 0.0528 
p__Cyanobacteria 
c__4C0d-2 o__YS2 
↓ 0.1086 0.0420 0.0201 
f__Lachnospiraceae 
g__Anaerostipes 
↓ 0.0234 0.0063 0.0312 
Observed changes in OTUs in Pilo-noSE group (40 days after the injections: MSC,             
pilocarpine)  corresponding to the baseline (before the injections).  
 












↑ 0.0006 0.4958 0.0038 








↓ 0.2327 0.0472 0.0280 
f__Lachnospiraceae; 
g__Anaerostipes 
↓ 0.0515 0.000 0.0369 
Observed changes in OTUs in Diazepam group (40 days after the injections: Diazepam, MSC,              





















↑ 0.0000 0.0234 0.0038 
f__Staphylococcaceae 
g__Staphylococcus 
↑ 0.0000 0.0208 0.0039 
c__Bacilli;o__Bacillales 
f__Planococcaceae 
↑ 0.0000 0.0120 0.0177 
f__Corynebacteriaceae 
g__Corynebacterium 








↑ 0.0000 0.0078 0.0182 
f__Clostridiaceae 
g__Clostridium 
↓ 0.0264 0.0031 0.0187 
f__Lachnospiraceae 
g__Anaerostipes 
↓ 0.0191 0.0000 0.0225 
Observed changes in OTUs in Control group (40 days after the injections with saline)              








Experimental groups were established and fecal samples with the microbiota          
of interest were prepared for the future inoculations and analysis.  
Cultivation of bacteria and MALDI-TOF MS analysis revealed particular species          
that are less present in all groups injected with pilocarpine (Pilo-SE, Pilo-noSE,            
Diazepam). These are ​Staphylococcus sciuri and ​Staphylococcus aureus​. On the          
other hand, ​Acinetobacter johnosnii​, ​Staphylococcus cohnii and ​Staphylococcus        
xylosus​ appeared only in these groups. 
Particular species were found only in Diazepam group, but it is important to             
note that ​Acinetobacter lwoffii is similar to ​Acinetobacter johnsohnii​, and it was            
detected in 11% what corresponds to one biological sample. Therefore there is            
a high probability of false detection or a contamination from environment.  
For the same reason it could be suggested the contamination from           
environment in case of ​Paenibacillus glucanolyticus ​and ​Enterobacter cloaceae​.         
Staphylococcus nepalensis and ​Staphylococcus xylosus in analyzed samples        
looks similar hence it can be assumed the only presence of the ​S. xylosus​. 
Although cultivation of bacteria already elucidated some patterns of the          
bacterial species distribution, it was reported that from the entire bacterial           
population of the GI tract of a 10​4 ​organisms only 10-50% can be cultivated.              
Thus, cultivation and following MALDI-TOF MS analysis can provide an          
additional insight on the presence of exact bacterial species, but it is not             
representative enough to characterise microbiota composition in the sample. 
Recent advances in DNA-based approaches, including qPCR and        
high-throughput sequencing, allow to determine almost 100% of species in the           
sample ​(Zoetendal, Collier, Koike, Mackie, & Gaskins, 2004)​. 
 
Thus, to reveal particular characteristics for each experimental group the          
DNA-based characterisation of the microbiota of the donors was performed.  
Analysis of the fecal samples from the mice with TLE (Pilo-SE group) revealed             
that after the induction of epilepsy there is no significant difference in number             
of genera (P = 0.146), but there is a significant difference in richness of              
microbiota in samples (P = 0.028) in comparison with baseline (before the            
injections). 
The changes in  
● f__Planococcaceae;  
● f__Staphylococcaceae, g__Staphylococcus;  
● f__Clostridiaceae, g__Clostridium  
correspond to the patterns in the control group and might be considered as             
age- and environment-related changes. 
Instead, changes in  
● f__Alcaligenaceae, g__Sutterella;  
● f__Prevotellaceae, g__Prevotella;  
● f__Lachnospiraceae, g__Dorea;  
● f__Erysipelotrichaceae, g__Coprobacillus  
● f__Clostridiaceae, g__Candidatus Arthromitus; 
might be considered as specific patterns for the group of animals that were             
injected with the pilocarpine, entered to the SE ​and developed chronic           
epilepsy. 
Interestingly, the group of the animals that were injected with the same            
protocol but did not enter to the SE and did not develop SRSs (Pilo-noSE group)               
in case of ​f__Clostridiaceae, g__Candidatus Arthromitus ​shows similar changes         
in the abundance of this genera in correspondence to the baseline.  
 
By now, limited amount of information regarding interaction of the certain           
bacterial genera with the CNS, but previously it was reported that in rats             
Candidatus Arthromitus was markedly increased in chronic variable        
stress-induced depression model in comparison with normal controls ​(Yu et al.,           
2017)​.  
And, at the same time, only in Pilo-noSE  group of animals  
● f__Bacteroidaceae g__Bacteroides  
● f__Lachnospiraceae, g__Butyrivibrio 
appeared to change significantly.  
Bacteroides ​spp. represents one of the largest genera inhabiting mammalian          
gut, so it is difficult to associate its abundance in this experimental group with              
particular pattern. In general, prevalence of this bacteria was reported to be a             
hallmark of “Bacteroides-driven enterotype” characterized by the increased        
intake of the animal fat and protein (high-fat/low-fiber), so-called “Western          
diet” ​(Wu et al., 2011)​. Recently this type of diet was reported to promote              
inflammation triggered by changes in microbiota composition ​(Zinöcker &         
Lindseth, 2018)​.  
More interesting is the fact that one of the strains ​f__Lachnospiraceae,           
g__Butyrivibrio - ​Butyrivibrio fibrisolvens MDT-1 produces butyrate - one of the           
most abundant SCFAs which was reported to stimulate growth of mucosa in            
the colon and to act as protective factor in case of colon cancer and              
inflammatory bowel disease ​(Hague, Singh, & Paraskeva, 1997)​. Moreover,         
used as probiotic, ​Butyrivibrio fibrisolvens MDT-1 ​was shown to alleviate the           
symptoms of the enterocolitis in rodents ​(Ohkawara, Furuya, Nagashima,         
Asanuma, & Hino, 2006)​.  
 
Apart from the antiinflammatory activity ​on site, ​SCFAs are already recognized           
as one of the communicational pathways in microbiota-gut-brain alliance         
(Samuel et al., 2008)​. 
As it was mentioned before, significant shifts in specific genera were observed            
only in animals with epilepsy (Pilo-SE group). 
Recently it was reported that increased levels of ​Sutterella ​genus may be            
involved in the pathogenesis of autism  ​(Ding, Taur, & Walkup, 2017)​.  
Also, in the study focused on the changes in microbiota composition during the             
lifespan, transgenic mouse model of the Alzheimer's disease were reported to           
have significant increase in ​Sutterella ​spp. in comparison with their wild-type           
littermates ​(Ding et al., 2017)​.  
On the other hand, the studies on mice colonized with microbiota from the             
patients diagnosed with MS highlighted reduction of ​Sutterella spp. as the           
most perceptible MS-dependent shift ​(Berer et al., 2017)​.  
Presence of ​Prevotella spp. in human is associated with the enterotype           
characterised by low-fat/high-fiber diet ​(Wu et al., 2011)​. Hypothetically         
high-fiber diet could be an excellent source of the dietary fibers that under the              
normal conditions are transformed by intestinal bacteria to SCFAs, which, as it            
was mentioned before play an important role in the gut-brain interaction. 
Dorea ​spp. also participate in fermenting dietary fibers into SCFAs. Species of            
this genera were shown to be associated with insulin resistance and systemic            
inflammation in obese rodents ​(Jiao et al., 2018)​. Moreover, prevalence of           
both, ​Dorea ​spp. and ​Coprobacillus spp. were reported to correlate with           
metabolic alterations which in turn are associated with cognitive impairment          
and cerebral hypometabolism ​(Sanguinetti et al., 2018)​. 
 
 
To investigate whether these genera ​per se might interfere with the threshold            
of the brain excitability and subsequent seizure activity, further investigations          
on bigger cohort of the animals and with more precise control of the bacterial              











Part II. Morphological and functional characterization of       
experimental groups 
Rationale 
In rodents, systemic administration of single dose of pilocarpine leads to status            
epilepticus (SE) and, after a seizure-free period, to a chronic condition           
determined by spontaneous recurrent seizures (SRSs). However, not all animals          
injected with convulsant dose of pilocarpine develop convulsive SE. These          
animals with non convulsive SE (noSE) are often excluded from the experiment            
or used as control group, instead of trying to understand the neurobiological            
substrate responsible for this “resistance”. In 2009, the long-term EEG effects           
induced by pilocarpine on noSE rats were demonstrated ​(Navarro Mora et al.,            
2009)​. This study highlighted that injected with pilocarpine rats without          
entering to the SE can have SRSs after a long period mimicking human             
pathology. 
Thus, as an adequate, paralleling human epileptogenesis animal model is still           
under the discussion it was decided to evaluate possible features in all            
established groups of animals including those who did not enter to the SE after              
the single injection of the pilocarpine (Pilo-noSE). Therefore in this part of the             
long-term study, characterization of bacterial population in donor groups was          
performed. Moreover, this part of the study is focused on functional and            
structural changes in the brain in order to widespread knowledge about           
long-term consequences of non convulsive status epilepticus in the mouse          
model of status epilepticus.  
  
 
Materials and Methods 
Magnetic resonance imaging (MRI) 
For the monitoring of brain alterations in epileptic disorders in research or            
clinical settings MRI technique in used ​(Bradley & Shey, 2000)​.  
In the present study animals underwent the MRI imaging 5 months after the             
induction od SE which refers to the chronical state of disease. 
Images were acquired using a Biospec Tomograph (Bruker, Karlsruhe,         
Germany) equipped with a 4.7 T horizontal magnet with 33 cm bore (Oxford             
Ltd, Oxford, UK). Mice were anesthetized by inhalation of a mixture of air and              
O​2 containing 0.5–1% isoflurane, and placed in prone position into a 7.2 cm i.d.              
transmitter birdcage coil. The signal was received through a helmet coil,           
actively decoupled from the transmitter coil, and placed directly on the           
animal’s head. 
After a sagittal scout image, 12 contiguous 1-mm-thick slices were acquired to            
cover the whole-brain using a RARE T2-weighted sequence with TR=5000 ms,           
TE=76 ms, FOV (field of view)=2x2cm​2​, NEX (number of average)=10, matrix           
size=128×128 for an acquisition time of 6 minutes and 40 seconds. Contrast            
enhancement (CE) was evaluated acquiring GRE images (TR/TE=350/15 ms, flip          
angle=30°, 12 contiguous 1-mm-thick slices, FOV=2x2 cm​2​,matrix size=256x192,        
NEX=2, acquisition time=2 minutes and 14 seconds) before and two minutes           
after intravenous administration of 0.3 μL of Endorem® (kindly supplied by           
Guerbet, Aulnay-Sous-Bois, France). Diffusion tensor images (DTI) were        
acquired with an EPI sequence optimized for the mouse head. Imaging           
parameters were set as follows: TR=3000 ms, TE=36 ms, FOV=2x2 cm​2​, matrix            
size=128x128 and 12 contiguous 1-mm-thick slices. Diffusion images were         
 
acquired in 12 non-collinear directions with b=750 s/mm​2 and three b0 images            
for an acquisition time of 36 minutes. 
Surgical implantation of electrodes 
At the age of eight months all animals of donors group were stereotaxically             
implanted with bilateral cortical (epidural) and hippocampal electrodes under         
isoflurane anesthesia (1.5 - 2%). Cortical silver electrodes (Safina, Czech          
Republic) were implanted over the left and right sensorimotor cortex (AP= +            
0.5 mm, ML= ±0.5 mm). In addition, isolated electrodes (PlasticsOne, USA)           
were implanted bilaterally into the left and right dorsal hippocampus (AP -2.3,            
ML ±2.5, DV 1.5). Ground and reference silver electrodes were placed over the             
cerebellum. All coordinates were determined according to “The Mouse Brain in           
Stereotaxic Coordinates”, (Paxinos and Franklin, 2001). All implanted        
electrodes were fixed to the skull with self-curing methacrylate resin          
(Duracrol® Dental, Prague). At the end of the surgery, anaesthesia was           
terminated and animals received analgesic drug (Rimadyl, 5 mg/kg). Mice were           




EEG - monitoring 
Electrical activity of the brain traced by the means of electroencephalography           
(EEG) is a crucial biomarker in a variety of neurological disorders, especially in             
pathologies characterised by increased brain excitability including epilepsy. It is          
easy applicable to the research animal model and offers high time resolution. 
The EEG registration system consist of 12-channels swivel (#AC6023, Moog,          
USA), 8-channels bioamplifier g.BSamp (Biosignal amplifier, gTec, USA) and         
16-bit analog​-to-digital converter (Power-Lab 8/35, AD Instruments, USA). The         
Labchart software v.8 (AD Instruments, USA) was used to record bioelectric           
activity. 
At the beginning of EEG-monitoring, animals were connected with a custom           
made 6-channels cables to the EEG system. Mice were individually placed into            
the plexiglass cages (18x18x20 cm) with free access to food and hydrogel. In             
addition, all plexiglass cages were placed into individual boxes with controlled           
12:12 dark/light cycle, temperature control and sound isolation (Ugo basile,          
USA). Free movement of the animals was guaranteed by the electrical swivel            
mounted to the top wall of the box. 
Registration of brain electrical activity was performed with the amplification          
1000x at the range +/- 5V, and hardware based filters ( band-pass filter             
0.5-1000 Hz). Recorded signal was digitized at the sample frequency 1kHz. In            
total,  48h of EEG were recorded for each animal. 
 
Analysis  
Left sensorimotor and hippocampal channels in reference to cerebellum were          
selected for the analysis (incidence of seizures and total power). Analysis was            
done offline using the LabChart v.8 (AD Instruments, USA) software and           
custom-made Matlab script (MathWorks, Natick, MA, USA) for every animal          
 
individually. The analysis of total power was done for each channel           
continuously with a 5s-window for delta (0.5-4 Hz), theta (4.5-8 Hz), alpha            
(8.5-13 Hz), beta (13.5-24 Hz) and gamma bands (25-70 Hz).  
In future analysis relative power for each EEG-band in the 5s-window was            
calculated by normalization to the corresponded total power (sum of all band            
powers). In addition, relative total power values was firstly averaged for every            
hour to evaluate possible impact of the light/dark phase on the EEG-pattern.            
At the end, we performed average of whole period of EEG recording (i.e. 24h)              
for individual animals and this value was used lated for statistical analysis.  
Statistical analysis was done with GraphPrism v.7 (GraphPad Software Inc., CA,           
USA) and Matlab (MathWorks, USA). The one-way ANOVA test followed by           
multiple comparisons was used for the test of significance. The level of            
significance was defined as p <0.05. 
Auditory Event Related Potentials (ERPs) 
Event-related potentials (ERPs) are very small voltage fluctuations generated in          
the brain in response to specific events or stimuli ​(Blackwood & Muir, 1990)​.             
Being a ​time-locked EEG activity this method offers an excellent ​temporal           
resolution and may suggest an additional insight for the understanding of the            
functional state of the brain including both sensory and cognitive-related          
processes.  
It provides a continuous measure of stimulus processing at different          
anatomical levels and it ​can be divided into 2 categories. The early components             
reflect “sensory” respond to the given stimuli and later components represents           
how the subject elaborate this signal, indicating ‘cognitive’ part of the           
information processing ​(Sur & Sinha, 2009)​.  
 
 
All components can be visualized in the waveforms P1, N1, P2, N2, P3 (see              
Fig.7): 
 
Figure 7. Schematic representation of the ERP. 
● P1 
The P1 peak is a positive evoked potential that in human usually appears 50 ms               
after the stimulus and its form can indicate a filtering process of irrelevant             
information ​(Witten et al., 2016)​. This peak is generated laterally in the            
Heschl’s gyrus, in the primary auditory cortex ​(Liégeois-Chauvel, Musolino,         
Badier, Marquis, & Chauvel, 1994)​.  
● N1 
The N1 peak is a negative peak between 90 and 200 ms after the onset of                
stimulus which reflects the perception of the signal and detection of the            
changes in the auditory environment ​(Arnott, Bardouille, Ross, & Alain, 2011;           
Ullsperger, Freude, & Erdmann, 2001)​. It originates from: the auditory cortex,           
vertex and from a source in the superior temporal gyrus ​(Luck, 2012)​.  
● P2 
The P2 appears around 100-250 ms after the stimulus and current evidence            
suggests that together with the attentional allocation it is associated with a            
categorization process ​(Paiva et al., 2016)​.  
 
● N2 
The N2 peak was shown to be involved in categorization process, stimulus            
evaluation and discrimination ​(Vaitkevičius, Kaubrys, & Audronytė, 2015)​.  
 
● P3 
P3 in clinical is recognized as a positive evoked potential that appears around             
300 ms and its latency has been defined as an index of cognitive efficiency              
(Kutas, McCarthy, & Donchin, 1977)​. This component was studied a lot in            
relation with epilepsy and P3 latency prolongation was reported to be an            
important clinical marker for the seizures duration and frequency ​(Caravaglios          
et al., 2001; Fukai, Motomura, Kobayashi, Asaba, & Sakai, 1990)​.  
  
In the present study auditory ERP was used to evaluate functional differences            
between experimental groups.  
For ERP registration the same set up as for the EEG was used with the               
sensitivity increased (voltage range +/- 1V) and sample frequency 4 kHz. 
ERP was registered during the dark phase. Respond for auditory stimuli was            
recorded. 
Based on the previous studies conducted in our laboratory the following           
procedure was used: 
For each animal two protocols were applied, in both protocols non-target (nt) –             
low frequency stimuli were presented in 80%, target (t) - high frequency stimuli             
were presented in 20%. 
 Table 7. Protocol of the audial stimuli application. 
  Non-target stimuli frequency, Hz Target stimuli frequency, Hz 
Protocol 1 4 6 
Protocol 2 4 8 
  
 
ERPs were elicited with a passive acoustic oddball paradigm. The sinusoidal           
sound tones were generated by a programmable online frequency signal          
generator. Speakers were located 18 cm above the animal. The event labels            
were sent by custom-made script in Matlab (R2015a, Mathworks, USA) and           
StimTracker (Cedrus, San Pedro, USA) via serial output into digital inputs of            
Power​Lab and stored directly in the Labchart file. 
  
In total in each protocol 320 stimuli were applied. Stimuli were interspersed            
randomly, each tone with 50 ms of duration and 78 db SPL of loudness.              
Interstimulus interval was also randomized from 1.7 seconds to 2.1 seconds.           
Two stimulation protocols were used randomly, interval between protocols         
was 24 hours. 
 
Analysis of the signal  
Offline filtering was performed using LabChart, Notch filter (50 Hz) was applied            
and the bandpass was set at 0.1​-70 Hz. ERP analysis was performed using a              
custom-made script in Matlab (R2016b, Mathworks, USA).  
Firstly, the zero-phase filtering and artefacts removing were done. Then,          
segmentation of the EEG signal was performed: in the window -600 before and             
1100 ms after the trigger (stimuli). From all corresponding segments for t and             
nt stimuli (for every channel, every mouse) , the grand average ERP was             
constructed and used for the later analysis.  
This grand average ERP was visualized for every single subject and after the             
visual inspection of the curves some animals were excluded due to the bad             
quality of the signal.  




Neuroimaging was performed 5 month after the induction of status epilepticus           
to evaluate structural alterations of brain regions of microbiota donors.          
Diffusion Weighted Images (DWI), T2-weighted images and perfusion maps         
were obtained and following analysis were done for auditory cortex,          
cerebellum, entorhinal cortex, hippocampus, sensorimotor cortex, thalamus       
and visual cortex. Analysis of the DWI and T2-weighted images did not show             
significant alterations between the experimental groups. Similarly, evaluation        
of the contrast enhancement did not reveal alteration of perfusion in all brain             
regions of interest except hippocampus. 
In hippocampus, the one-way ANOVA analysis with following Holm-Sidak post          
hoc test (F (3, 37) = 4.703, P=0.007) showed significant differences in contrast             
enhancement Pilo-SE versus Diazepam and Pilo-noSE groups  (Fig 8A). 
Similarly, analysis of the axial diffusivity showed significantly increased         
coefficient (one-way ANOVA with following Holm-Sidak post hoc test: F (3, 41)            
= 12.33, P < 0.0001) in the Pilo-SE group in comparison with other             
experimental groups (Fig 8B). Likewise, the ratio of normalized signal of radial            
diffusivity was significantly higher (one-way ANOVA with following Holm-Sidak         
post hoc test (F (3, 41) = 9.401, P < 0.0001) in the Pilo-SE group in comparison                 




Figure 8. MRI imaging of the animals 5 months after the induction of the SE (Control n=6,                 
Pilo-SE n=11 , Pilo-noSE n=13, Diazepam n=15). Asterisk indicates the significant (p<0.05)            
difference in comparison with Pilo-SE group. A. The coefficient of the contrast enhancement             
ratio in donors of microbiota. B. The normalized signal of axial diffusivity C. The normalized               
signal of radial diffusivity. 
 
EEG: occurrence of seizures and power spectral density analysis 
In a long-term observation (8 months after drugs injection) in all groups, except             
controls, epileptic seizures were found. Epileptic activity were represented by          
slow polymorphic spikes (2.5-4.5 Hz) and fast-runs activity (6-14 Hz). Whereas           
in Pilo-noSE and Diazepam groups mostly ictal hippocampal seizures were          
present (~89 %), in the Pilo-SE mice ~76% of seizures were present in             
hippocampus and sensorimotor cortex as a result of secondary generalization.          
Moreover, in all animals injected with pilocarpine, a continual interictal activity           
represented by short discharges (~3 s) and sharp spikes was observed in            
hippocampal and cortical EEG. Also in control group isolated spikes and slow            
polymorphic discharges were observed, however this activity never been         
continual, therefore, it can be associated with electrodes implantation and also           
with aging.  
In analysis of seizures we focused on presence and duration of fast-runs            
activity (6-14 Hz) in the hippocampal channel with duration ≥ 5s. One-way            
 
ANOVA analysis and following Sidak post hoc test revealed significant          
differences in the incidence of seizures (Fig. 9) between Pilo-SE and Pilo-noSE            
groups (F (2, 11) = 5.4, P = 0.0238). In groups after Pilo injection all other                




Figure 9. Representation of the:  
A. incidence of the epileptic seizures in donors of the microbiota in hippocampal channel 
(Mean±SEM). 
Axis Y represents amount of seizures counted in the 24 hours of EEG monitoring . On the 
axis X - experimental groups. Each symbol represent the value for individual subject. 
Asterisk (​*​) indicate significant difference in comparison with the Pilo-noSE group. 
One-way ANOVA analysis and following Sidak post hoc test revealed significant differences 
between Pilo-SE and Pilo-noSE groups (F (2, 11) = 5.4, P = 0.0238). 
B. Total duration of the seizures (Mean±SEM) in the 24 hours of EEG recording.  
Axis Y represents total time of the seizures duration (in minutes) calculated in the 24 hours 





Using bipolar derivation (hippocampus channel to sensorimotor cortex        
channel) amount of sharp-spikes (Fig. 10) in all groups was calculated. The            
statistical analysis using one-way ANOVA and following Sidak post hoc test           
revealed the significant significant increase of spikes count by ~ 30-45% in the             
Pilo-SE and Pilo-noSE groups in comparison to the Control group (F (2, 9) =              
0.4888, P = 0.6287). 
 
 
Figure 10. Appearance of sharp-spikes during EEG monitoring (24h) in microbiota donors 
(Mean+SEM). 
Axis Y represents increased occurence of spikes in percentage in comparison to Control 
group. On the axis X - experimental groups 8 months after Pilo injection. Asteriks (*) indicate 




Moreover, the power spectral density (PSD) analysis was obtained to          
characterize changes in individual EEG frequencies in microbiota donors.         
Analysis of PSD did not showed differences in between light and dark phases of              
the EEG monitoring therefore PSD for all period of observation (24h) was            
averaged for every individual animal and used for statistical evaluation. The           
changes in XXX frequencies were observed (Fig . 11). 
 
 
Figure 11. Representation of the normalized total power in the sensory-motor cortex (Ch1) 
and hippocampus (Ch2) of donors of the microbiota (Mean ± SEM). 
Axis Y represents normalized total power. On the axis X - experimental groups. 
Significant differences (p < 0.05) determined by one-way ANOVA and following Sidak post 
hoc test are represented with asterisks  (*) indicating significant difference in comparison 









Besides, ratio between low/high frequencies to the dominant frequency in          
rodent’s brain (theta) was calculated (Fig. 12).  
 
 
Figure 12. Representation of the ratio of the total power in the sensory-motor cortex (Ch1)               
and hippocampus (Ch2) of donors of the microbiota (Mean ± SEM). 
Axis Y represents the ratio. On the axis X - experimental groups. 
Asterisks indicate significant difference in comparison with the Control group, black dots -             
versus Pilo-SE. 
Significant differences (p < 0.05) determined by one-way ANOVA and following Sidak post 
hoc test are represented with black dot (●) - in comparison to Pilo SE asterisk (✽) - in 




As it was mentioned above, to evaluate a long-term consequences of SE on the              
cognitive processing, auditory ERPs were performed 8 months after drugs          
administration. The results are represented in Fig. 13. 
 
Figure 13. Amplitude of the auditory evoked potentials in the sensory-motor cortex and             
hippocampus of donors of the microbiota (Mean ± SEM). 
White bars represent non-target stimuli (4 kHz), black bars - target (8 kHz). Axis Y represents                
amplitude of the evoked responses in mV. On the axis X - grouped columns corresponding to                
the ERP peaks. 




Two protocols of auditory ERPs were used 4/6 kHz(nt/t) and 4/8 kHz (nt/t)             
always in 80/20 % of stimuli representation. In our study we did not found any               
relevant and significant changes with 4/6 kHz protocol was used (data not            
shown). Therefore we focused on ERP changes in the 4/8 kHz (nt/t) stimuli.  
In a Control group two-way ANOVA analysis revealed significant differences in           
both sensorimotor cortex and dorsal hippocampus channels in between         
non-target and target stimuli (F (1, 120) = 27.74, P < 0.0001). Following Sidak              
post hoc test showed significantly (P < 0.05) higher amplitude of target            
response for BL-P1 and P1-N1. 
In Pilo-SE group two-way ANOVA analysis revealed significant differences in          
both sensorimotor cortex and dorsal hippocampus channels in between         
non-target and target stimuli (F (3, 100) = 8.701, P < 0.0001). Following Sidak              
post hoc test showed signif (P < 0.05) higher amplitude of target response for              
BL-P1, P1-N1, N1-P2 (only in cortical channel), P2-N2,  N2-P3. 
In Pilo-noSE group two-way ANOVA analysis revealed significant differences in          
both sensorimotor cortex and dorsal hippocampus in between non-target and          
target stimuli (F (3, 60) = 10.62, P < 0.0001). Following Sidak post hoc test               
showed significant (P < 0.05) higher amplitude of target response for BL-P1,            
P1-N1, N1-P2 (only in hippocampal channel), P2-N2,  N2-P3. 
In Diazepam two-way ANOVA analysis revealed significant differences in both          
sensorimotor cortex and dorsal hippocampus channels in between non-target         
and target stimuli (F (3, 160) = 15.37, P < 0.0001). Following Sidak post hoc test                
showed significant (P < 0.05) higher amplitude of target response for BL-P1,            





Despite the fact that epilepsy appears to be one of the most severe             
neurological disorder in the world and a great number of the clinical and             
laboratory ​in vivo studies are focused in revealing and elucidating the exact            
pathogenesis and possible treatments of this disorder, to date there are still            
debates on the adequate animal model that will resemble human pathology. 
It was shown that SE - a crucial event in the animal model of the               
epileptogenesis - in humans is not so valuable for the prognosis: in patients             
experienced acute symptomatic SE the risk of spontaneous seizure activity          
after a 10 years follow-up was only 41% ​(Hesdorffer, Logroscino, Cascino,           
Annegers, & Hauser, 1998)​. 
What is more, in the experimental model of the TLE (pilocarpine-induced           
epilepsy in Wistar rats) it was shown that the group of the animals that was               
injected with the pilocarpine but did not experienced convulsive SE, in the            
long-term prospective (8/+22 months after) exhibit spontaneous seizure        
activity disregarding the lack of the initial acute injury (SE). 
 
The present study reports that NMRI mice who did not enter to the convulsive              
SE (Pilo-noSE), after a long latency period (8 months) actually experience non            
convulsive seizure activity in the dorsal hippocampus.  
Moreover, structural characterization of the experimental groups revealed that         
at the time-point of 5 months after the induction of epilepsy only Pilo-SE group              
had structural alterations in hippocampus that can can be a manifestation of            
the vasogenic edema after the acute SE. Other groups did not experienced            
such severe response to the same amount of the Pilo. 
 
On the other hand, evaluation of the functional shifts and electrophysiological           
patterns suggests that these animals (Pilo-noSE) due to the increased presence           
of the gamma activity, known to be associated with the neuronal pathology            
(Uhlhaas, Pipa, Neuenschwander, Wibral, & Singer, 2011)​, have altered         
excitability of the brain that is also represented by shifted gamma/theta ratio.  
Regarding investigation of the ERPs in these animals, data from the previous            
studies performed in our lab on 4 months old male NMRI mice, suggests that in               
intact control animals respond to the target stimulus (8kHz) is significantly           
higher than in the mice with the neuronal pathology. However, in present            
study control mice show no differences in response to target (8kHz) vs            
non-target (4kHz) stimuli in late components (i.e P2-N2, N2-P3). As ERPs were            
performed when mice were 10 months old, this can be explained by            
age-related conditions of the animals. In addition, another protocol of the           
stimulation was applied using different frequencies for the stimuli: nt - 4, t-6             
kHz (data not presented here) - also in this case no differences in late              
components in control animals were determined. 
Interestingly, all groups who received pilocarpine (Pilo-SE, Pilo-noSE,        
Diazepam) show significantly higher respond in the late component to the           
target signal in comparison with the corresponding non-target one. This          
finding, taken together with the higher presence of pro-pathological         
gamma-band in eeg in this animals can be associated with the higher            
excitability of the brain. 
This suggests that even with the lack of the initial acute SE, animals from the               
Pilo-noSE group experience functional alterations similar to those of the          
animals after the convulsive SE. 
Taking together, we suggest that the absence of the acute convulsive SE and             
evident structural deviations, long-term “silent” period before the appearance         
 
of the spontaneous seizure activity and altered excitation of the brain in the             
animals who usually do not respond “in a normal way” to the standard             
injection of the pilocarpine (and therefore that are excluded from the studies),            
can, actually, mimic human epileptogenesis in a more physiological way. Thus,           
further investigations, with the particular focus on this group of animals, are            
required. 
 
The exact mechanisms underlying such different response of the animals to the            
pilocarpine still have to be investigated and revealed. Among others, also           
intestinal microbiota can be an important partaker in the complex background           
of the host that makes it more of less susceptible to the induction of the SE. 
Future DNA-analysis of the fecal samples may provide additional insight on the            
possible correlations between the baseline microbiota composition and        
response to the induction of the SE with the pilocarpine.  
 
Indeed, already in 2012 it has been proposed that the microbiota of the             
laboratory rodents should be included in the hygienic standardization ​(Bleich &           
Hansen, 2012)​. Accumulating data suggest that the the composition and the           
state of the commensal microbiota can profoundly affect the performance of           
disease models, so it is no more a question of monitoring only potentially             
pathogenic species, but it is time of more “holistic” approach and control of             
the entire microbiota composition assuring better standardization of the         






Part III. Effect of the transplanted pro-pathological microbiota        
on the excitability of the brain 
Rationale 
The aim of the study is to test the hypothesis that gut microbiota from              
subjects affected by neural pathology can modulate in healthy subjects          
excitability in CNS and finally positively correlate with the level of seizure            
activity. 
The purpose is to determine the impact of a transplanted microbiota           
(from animals with epilepsy) on animals (pups) in which the disease is absent,             
in order to clarify whether (i) the presence of the disease can change             
microbiota in the gut to the point of having a “pro-pathological” microbiota; (ii)             
if the microbiota from animals with epilepsy can ​per se ​provoke the excitability             
of the the brain appearing through the lowering the threshold of the seizures.  
 In this step, the fecal microbiota obtained from the experimental groups           






Figure 14. Flowchart of the experiment. 
 
During the experiment animals were kept in the facility equipped with the            
multiple IVC cages, all manipulation were performed under the hood. This type            
of housing was chosen to provide optimal protection of the microbiota of            
interest from the environment in every step of the experiment. Lundberg et al.             
who tested the efficacy of the housing animals colonized with the complex            
microbiota in multiple IVC cages vs isolator, reported that (i) colonization was            
equally efficient in isolators and IVCs, (ii) the bacteria community of the donor             
 
was exhibited in both housing systems, (iii) 16S rRNA gene sequencing did not             
reveal any increase in bacterial diversity in the IVC cages ​(Lundberg, Bahl, Licht,             
Toft, & Hansen, 2017)​. 
 
To provide the best condition for settling down microbiota in the acceptor            
organism several steps before the transplantation were made: 
Mice, after the habituation period of 2 weeks, were mated and from the 12​th              
day of pregnancy till the delivery of the pups a cocktail of antibiotics was              
applied.  
To avoid the degradation of the antibiotics in the drinking water (due to the              
light exposure and long-term keeping in the room temperature) and to provide            
optimal dosing and uninformed mixing levels, antibiotics were changed every          
24 h. 
Only male pups were processed as in the last step animals were went through              
the pilocarpine challenge. 
 
A single oral inoculation of the microbiota of interest were showed to be the              
most efficient at three weeks of age ​(C. H. F. Hansen et al., 2012)​. Thus, FMT                
were performed twice in P21 and P24 by oral gavage and, in addition, by              
contaminating the cage of acceptors with fecal pellets of donors. All           
procedures were performed under the hood in SPF environment and during           
handling procedures to provide maximal microbiological safety and reduce the          





7 days after settling down the microbiota of interest mice were visually            
observed (4 hours per day, 3 days) to reveal the appearance of SRSs. As              
behavioural manifestations were not revealed, mice underwent the        
implantation of the cortical electrodes for the electrophysiological evaluation.         
For each animal 48 hours of EEG was recorded and auditory ERPs were             
performed. 
Finally, in order to evaluate the susceptibility of the animals to epilepsy, mice             







Materials and Methods 
Animals 
NMRI mice (Charles River, France) 4 weeks old were kept in the animal facility              
of the University of Verona in the individually ventilated cages (IVC) with the             
sterile standard food ​and bottled autoclaved tap water ​ad libitum​, without           
dietary variation within the study.  
After the 2 weeks of habituation animals were mated. From the 12th day of              
pregnancy a mix of antibiotics (Ampicillin 1g/L, Vancomycin 0.5 g/L, Neomycin           
1 g/L) was added to the autoclaved drinking water till the delivery of pups. The               
male pups were weaned to the three weeks of age, then randomized into 4              
groups (Pilo-SE, Pilo-noSE, Diazepam, Control). 
  
Gut microbiota transfer 
Immediately after collecting, fecal samples from the donors were divided into           
aliquots and frozen at -80 in 30% Glycerol/PBS solution. 
At the day of inoculation fecal samples were extracted from the Glycerol/PBS            
solution and vortexed with PBS.  
At the age of P21 and P24 inoculated by oral gavage with corresponding fecal              
samples homogenized with PBS solution (50 μl/mouse) per mouse. All          
manipulations were performed under the hood in the time interval 9am -            




As described in Part II. With the exception that instead of the deep             
hippocampal electrodes cortical silver electrodes over left and right parietal          
 
cortex (AP -2.3, ML ± 2.4) were implanted. All coordinates were calculated            
according to Bregma-Lambda distance for every animal according to “The          
Mouse Brain in Stereotaxic Coordinates”, (Paxinos and Franklin, 2001). 
  
EEG 
As in Part II with the addition that instead of the averaging of the whole period                
of EEG recording (i.e. 24h) for individual animals , average was done for every              
minute for individual animal and used later for statistical analysis. 
Statistical analysis, as in the previous study, was done with GraphPrism v.7            
(GraphPad Software Inc., CA, USA) and Matlab (MathWorks, USA). The          
one-way ANOVA test followed by multiple comparisons was used for the test            
of significance. The level of significance was defined as p <0.05. 
Next, for every animal we calculated an average total power for each EEG-band             
of a baseline EEG for each EEG-band. And corresponding average value was            
used later for the normalization of the MS and Pilo signal. 
  
ERP 
As in Part II. 
Pilocarpine challenge 
Resemble the protocol for the induction of the TLE in rodents. For the             
pilocarpine challenge subclinical dose of the pilocarpine was used (260 mg/kg)           
instead of 300 mg/kg. 30 minutes prior to the pilocarpine mice were injected             
with methylscopolamine. Animals were connected for the EEG recording and          
the clinical state was controlled visually for 160 min. Animals who did not enter              









Figure 15. Survival curves in response to the pilocarpine challenge of the first (pilot group). 
Curves on the graph represent the corresponding groups: Control (dotted black line), Pilo-SE 
(black line), Diazepam (green) and Pilo-noSE (blue). Axis Y represents percentage of animals 
entered to SE, X - time in minutes. Yellow line indicates the time of the pilocarpine injection, 
red one - end of the observation. Comparison of the curves showed significant difference 
between Control and Pilo-SE groups (Logrank test, Chi square 11.95, p = 0.0076), and 







EEG: occurrence of seizures and power spectral density analysis 
 
Control group         Pilo-SE group 
 
Figure 16. Representation of the gamma-band in 24h EEG recording. 
Profile of time changes in the relative gamma (25-70 Hz) total power in the sensorimotor 
cortex of receivers of the microbiota. 
Each row represents individual animal and X axis indicate time in hours. Changes in gamma 
visualized  in colored scale (from grey as minimal to maximal - brown) as a ratio to the total 





Figure 17. Spikes counting in the 24 hours of the EEG recording. 
Appearance of the spikes in the sensory-motor cortex of animals inoculated with microbiota 
(Mean ± SEM). 
Axis Y represents average spikes-count calculated in the 24 hours of EEG monitoring. Axis X 





Figure 18. Amplitude of the auditory evoked potentials in the sensory-motor cortex of 
receivers of the microbiota (Mean+SEM). 
White bars represent non-target stimuli (4 kHz), grey bars - target (8 kHz). Axis Y represents 
amplitude of the evoked responses in mV. On the axis X - grouped columns corresponding to 
the ERP peaks. 







Figure 19. Survival curves in response to the pilocarpine challenge. 
Curves on the graph represent the corresponding groups: Control (dotted black line) and             
Pilo-SE (black line). Axis Y represents percentage of animals entered to SE, X - time in                
minutes. Yellow line indicates the time of the pilocarpine injection, in the time point of 120                
minutes animals who did not enter to the SE received an additional dose of the pilocarpine. 
Comparison of the curves showed significant difference between two groups (Logrank test,            






For the present study so-called “virtually germ free” mouse model was chosen.            
This refers to the depletion of the host microbiota with the mix of antibiotics              
that cover wide spectrum of bacterial species. This model has its limitations            
and as the complete germ-free status is not obtained, the variation in the             
survived species can be observed. On the other hand, GF mice, as a potential              
model to study epilepsy, have an abnormal baseline and lack of the early-life             
immune priming which is crucial for the normal development of the immune            
system. What is more, even brief postnatal GF period changes levels of            
systemic regulatory immune cells and cytokine production ​(C. H. F. Hansen et            
al., 2012)​. As it was described before, immune signalling molecules can play an             
important role in the microbiota-gut-brain interaction, thus “virtually germ         
free” mouse model, taking in consideration all its limitations, appears to be            
more appropriate to study possible impact of the microbiota on the excitability            
of the brain. 
Results of the pilocarpine challenge in the first (pilot) group suggested the            
possibility that pro-pathological microbiota obtained from the Pilo-SE donors         
may lead to the lowering of the seizures threshold in recipients. Interestingly,            
pups inoculated with Pilo-noSE microbiota (from donors who did not enter to            
the SE after the injection of the pilocarpine, but in Part II were shown to have                
seizures in the hippocampus) also were more susceptible in the challenge with            
the subclinical dose of the pilocarpine. As the number of the animals in each              
group was limited, additional runs of the experiment were performed.  
 
In the next runs we decided to concentrate on the main experimental groups:             
Pilo-SE and Control.  
 
After the inoculation with the microbiota of interest pups were monitored for            
the detection of spontaneous seizures. Visual observation, together with the          
electrophysiological data (EEG, ERP) reveals that:  
● Inoculation with the pro-pathological microbiota was not sufficient to         
provoke behavioral manifestations of the seizure-like activity.  
● Baseline EEG recording reveal slight alterations in the presence of          
gamma band in individual animals. Gamma waves (25-70 Hz),         
representing high frequency activity of the brain, usually indicate the          
pathological state of the brain (altered excitability which is leading to the            
lowering seizures threshold).  
● Average amount of spikes in mice inoculated with the pro-pathological          
microbiota was the same as in control group, which leads to the idea             
that inoculation with the pro-pathological microbiota ​per se was not          
sufficient to elucidate the differences in the groups. The presence of the            
spikes in control groups can be due to the surgical implantation of the             
electrodes which by itself might cause a microinflammation.  
● Evaluation of the respond to the auditory stimuli did not reveal any            
significant functional differences between two groups (Pilo-SE vs        
Control). 
● During challenging animals with the pilocarpine, mice who received         
microbiota from the Pilo-SE donors appeared to have lower threshold          
for the seizure activity. This suggests that mice received         
“pro-pathological” microbiota have compromised excitability     




In this study epilepsy was used as a hyperexcitability paradigm. Thus,           
challenging mice with the subclinical dose of pilocarpine (260 mg/kg instead of            
300) is mimicking any challenge for immune system that can spontaneously           
occur (fever, flu, etc.)  
The data of the present study suggests that the microbiological background of            
the host can have an important role in the response of the organism to the               
events challenging the excitability of the brain.  
This supports the growing body of literature that underlines the crucial role of             
the gut microbiota in development, progression and even improvement of the           
CNS pathologies including depression, stroke ​(Winek, Dirnagl, & Meisel, 2016)          




The idea of the microbiota-gut-brain interaction is relatively young and          
constantly developing. Great breakthrough has happened recently and is         
happening now, but there is still a lot to discover. 
In the studies described above we aimed to investigate the possible impact of             
the microbiota obtained from the donors - mouse model of TLE on the brain              
excitability of the healthy recipients. Data presented here suggest that animals           
who received “pro-pathological” microbiota have compromised excitability,       
considering that this group appeared to have lower threshold for developing           
seizure activity. Microbiota composition of the donors with induced TLE was           
characterised by the increase in ​Sutterella, Prevotella, Dorea, Coprobacillus ​and          
Candidatus Arthromitus ​in comparison with the baseline, what hypothetically,         
through the GBA, might have an effect on the excitability of the brain and              
subsequently on the threshold for the development of the  seizures. 
 
To some point, the idea that seizure activity can be moderated by the             
gastroenterological interventions is not new. Ketogenic diet (KD) is known to           
be an effective treatment for the drug-resistant epilepsy in children and to            
provide beneficial effect in adults ​(Liu et al., 2018)​. But only recently intestinal             
microbiota was recognized as the active contributor to this effect. New findings            
suggest that in infants with diagnosed epilepsy, after following KD, bacterial           
patterns were significantly changed and, what is more, changes in microbiota           
composition correlated with the reduction in the seizure activity ​(Xie et al.,            
2017)​.  
 
Nowadays the growing body of literature suggests that patients with various           
neurological disorders can potentially benefit from the interventions regarding         
intestinal microbiota.  
For instance, it was shown that in animal model of MS, administration of             
human commensal bacterium ​P. histicola provide evident immunomodulatory,        
anti-inflammatory response and reduce demyelination, thus may be        
considered for treatment strategies for MS ​(Mangalam et al., 2017)​. Recent           
issue of the Neurotherapeutics (January 2018) was completely dedicated to the           
role of the microbiome in neurologic diseases. It covers explicitly the           
intersections between MS and the state of the microbiota community in the            
gut, raising a lot of open-questions, and, at the same time, underlying the             
importance of considering this “forgotten organ” in the incidence and          
progression of the MS and possibilities for the management of the disease            
outcome. 
Also, in the recent review regarding the role of the intestinal microbiome in             
ASD, potential therapeutic strategies such as probiotic treatment and FMT          
were highlighted ​(Mangalam et al., 2017)​. In the mouse model of ASD, KD was              
shown to modulate the microbiota composition and potentially contribute to          
alleviation of neurological symptoms associated with the disease ​(Newell et al.,           
2016)​. Another studies performed on the animal model showed that          
administration of the human commensal bacteria (​Bacteroides fragilis​)        
regulates gut permeability, influences microbial composition and improves        
ASD-related behaviors ​(Hsiao et al., 2013)​. 
In the case of AD, nutritional interventions were shown to influence the            
composition of the gut microbiota and subsequently affect the formation and           
aggregation of cerebral amyloid-β, several “antiamyloidogenic” and       
 
“proamyloidogenic” products were identified for the targeted personalized        
nutrition protocols in patients with AD ​(Pistollato et al., 2016)​.  
Also, several probiotics were reported to improve memory deficit in          
experimental models ​(Athari Nik Azm et al., 2018; Nimgampalle & Kuna, 2017)            
and to alleviate AD-related impairments in randomized clinical trial as well           
(Akbari et al., 2016)​.  
 
To summarize, evidence from both experimental and clinical research suggests          
that probiotics, prebiotics, FMT and nutrition-based therapies targeting        
gut-brain axis may become a safe and powerful support for the patients with             
the incurable forms of neurologic diseases . Thus, to elucidate exact pathways            
of microbiota-gut-brain interaction for targeted and effective therapeutic        
strategies, further investigations in this promising and exciting field are          
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